CooperSurgical Holdings Limited, a prominent player in the medical device industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 1990, the company has established itself as a leader in women's health, focusing on innovative solutions that enhance reproductive health and fertility. Specialising in a range of products, CooperSurgical offers advanced medical devices, including surgical instruments and diagnostic tools, designed to improve patient outcomes. Their commitment to quality and innovation has positioned them as a trusted partner for healthcare professionals. With a strong market presence, CooperSurgical has achieved significant milestones, including strategic acquisitions that have expanded their product portfolio and global reach. Their dedication to advancing women's health continues to set them apart in a competitive landscape.
How does Coopersurgical Holdings Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Coopersurgical Holdings Limited's score of 34 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Coopersurgical Holdings Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as no figures are available. The company is a current subsidiary of The Cooper Companies, Inc., which may influence its climate commitments and emissions reporting. As of now, Coopersurgical Holdings Limited has not established any documented reduction targets or climate pledges. This lack of specific initiatives may reflect a broader industry context where many companies are still developing their sustainability strategies. Given the absence of direct emissions data, it is essential to monitor future disclosures from Coopersurgical Holdings Limited or its parent company, The Cooper Companies, Inc., for any updates on their carbon emissions and climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 29,747,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 33,442,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Coopersurgical Holdings Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.